The evaluation of an RBE for iodine 125 relative to iridium 192 from a human erythematous skin reaction using a new approach to skin scoring.
D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007495:Iridium / Q000627:therapeutic use*; D008297:Male; D009062:Mouth Neoplasms / Q000628:therapy; D011868:Radioisotopes / Q000627:therapeutic use*; D012062:Relative Biological Effectiveness; D012867:Skin / Q000528:radiation effects*; D013997:Time Factors
D007457:Iodine Radioisotopes; D011868:Radioisotopes; D007495:Iridium